Executive Committee

Hannes Iserentant is General Manager of the Company. He joined Celyad Oncology in 2016 and has held several positions in the company, most recently Head of Intellectual Property (IP). He is part of the Executive Committee since 2022. He started his IP career in private practice at Bird Goën & Co as a member of the life sciences team before moving to VIB, a research institute active in all areas of life sciences. He was a founding member of VIB’s technology watch team involved in identifying and securing access to early stage, emerging technologies. From 2013 to 2016, he was appointed as a member of the “Expert Group on the development and implications of patent law in the field of biotechnology and genetic engineering” for the European Commission. Mr. Iserentant holds a PhD in Biomedical Sciences from Ghent University and is a qualified European Patent Attorney and European Patent Litigator.